Physiological nitric oxide (NO) signal transduction occurs through activation of guanylyl cyclase (GC)‐coupled receptors, resulting in cGMP accumulation. There are five possible receptors: four heterodimers (α1β1, α2β1, α1β2, α2β2) and a presumed homodimer (νβ2). The present study investigated the kinetic and pharmacological properties of all these putative receptors expressed in COS‐7 (or HeLa) cells. All exhibited NO‐activated GC activity, that of α1β1 and α2β1 being much higher than that of the β2‐containing heterodimers or νβ2. All were highly sensitive NO detectors. Using clamped NO concentrations, EC50 values were 1 nM for α1β1 and 2 nM for α2β1. With α1β2, α2β2 and νβ2, the EC50 was estimated to be lower, about 8 nM. All the GCs displayed a marked desensitising profile of activity. Consistent with this property, the concentration–response curves were bell‐shaped, particularly those of the β2 heterodimers and νβ2. Confocal microscopy of cells transfected with the fluorescently tagged β2 subunit suggested targeting to the endoplasmic reticulum through its isoprenylation sequence, but no associated particulate GC activity was detected. The NO‐stimulated GC activity of all heterodimers and νβ2 was inhibited by 1H‐[1,2,4]oxadiazolo[4,3‐a]quinoxalin‐1‐one and, except for νβ2, was enhanced by the allosteric activator YC‐1. It is concluded that all the four possible heterodimers, as well as the putative νβ2 homodimer, can function as high‐affinity GC‐coupled NO receptors when expressed in cells. They exhibit differences in NO potency, maximal GC activity, desensitisation kinetics and possibly subcellular location but, except for νβ2, cannot be differentiated using existing pharmacological agents. British Journal of Pharmacology (2003) 139, 1032–1040. doi:10.1038/sj.bjp.0705318